Psychiatric research is one of the most complex medical endevors because the pathology underlying psychiatric disorders is located in the most complex organ, the brain, and the phenotype of psychiatric disorders is very heterogeneous. The articles in this double-issue of the Journal of Psychiatric Research demonstrate this complexity by addressing basic as well as clinical approaches, which should be regarded as complementary and can improve our understanding of psychiatric illnesses.

This double-issue contains several interesting articles on schizophrenia. [@bib4], for instance, review the results of diffusion tensor imaging (DTI) studies in schizophrenia, a method that makes it possible to evaluate the organization and coherence of cranial white matter fiber tracts. DTI provides a novel approach to understanding how specific brain regions are connected and how disturbances of these connections may tribute to cognitive and other clinical abnormalities observed in schizophrenia. The findings of [@bib5] is also in support of the hypothesis that structural damage to the brain plays a role in the pathogenesis of schizophrenia. They observed higher plasma levels of S-100b in schizophrenia, a protein assumed to reflect structural damage to the CNS. Applying proton magnetic resonance spectroscopy, [@bib11] found evidence for neuronal loss in the posterior cingulate gyrus in schizophrenia. The causes for these disturbances, however, are not completely understood. Reduced activity of neurotrophic factors like BDNF could be an explanation ([@bib2]). Beyond this, genetic alterations provide an important source of further factors explaining these disturbances. [@bib3] demonstrate that a genetic variant in a gene expressing the polypeptide epidermal growth factor (EGF) is associated with an early age at onset in male schizophrenic patients. This gene exerts neurotrophic and neuromodulatory effects on developing dopaminergic neurons, and lower postmortem levels of EGF family proteins were observed in the prefrontal cortex and striatum of schizophrenic patients. These findings suggest that genetically mediated effects on neuronal development might be involved in the vulnerability for schizophrenia, possibly by affecting the neuronal connectivity in cortical structures. Other theories postulate that altered immune system function is involved in the etiopathology of schizophrenia. [@bib10] addressed this by examining T cellular immune response in schizophrenic patients. They found diminished skin reactions to different antigens demonstrating a markedly attenuated T helper cell type-1 (Th-1) mediated immune response in these patients. Since Th-1 mediated immune response has been implicated in host defense against neurotropic pathogens, the findings by Riedel et al. points to another possible causation for an altered neuronal connectivity in schizophrenia. In this context, it is important to note that altered immune function is also discussed as etiopathological factors in depression and dementia. While [@bib6] did not find altered levels of Th-1 cytokines in unmedicated depressed outpatients, [@bib9] reported a premature immunosenescence in patients in an early stage of Alzheimer's disease.

Brain imaging, genotyping, and tests of immune system function are important methods to understand the biology of psychiatric illnesses. However, the description of pathology is incomplete without examining specific behavioral phenotypes. Tobacco use is a very predominant behavioral phenotype in schizophrenia. [@bib13] observed that cigarette smoking is associated with a higher degree of interpersonal problems and a higher frequency of relapse suggesting a major relevance for this phenotype on outcome of schizophrenia. Weight gain is another phenotype frequently observed in schizophrenia, particularly under treatment with atypical neuroleptics. Findings by [@bib1] suggest that alteration in leptin and nitric oxide regulation could be responsible for these side effects.

Clinical features affecting the long-term outcome in bipolar I disorder were the focus of a study presented by [@bib8]. The authors examined the relationship between certain variables of the clinical course of the past 5 years and outcome over the subsequent 5-year period. They found that the quantity and severity of affective states are greater predictors of affective burden in bipolar I patients than the number and direction of affective switches.

Environmental stressors are major risk factors for the development of psychiatric symptoms in exposed individuals. The outbreak of the Severe Acute Respiratory Syndrome (SARS) in 2003 was a major environmental stress factor for those exposed, which was primarily the case for medical personnel in the caring units. [@bib12] observed increased symptoms of depression and insomnia but not PTSD in nurses of a large SARS unit in Taiwan compared to nurses of other units. The symptoms improved during the study period of 4 weeks suggesting a gradual psychological adaptation to the stressor. Availability of positive coping strategies and strong social and family support acted as protective factors.

Perceived medical outcome and quality of life are important determinants of disease outcome. A number of standardized tests are available for evaluating quality of life and perceived medical outcome. They are important tools to evaluate the long-term consequences of illnesses. [@bib14] who reported differing patterns of quality of life and perceived medical outcome with respect to the course of posttraumatic stress symptoms in Taiwanese survivors of a severe earthquake during a 3-year follow-up study.

There is growing recognition that functional living skills indicating the degree of functional independence in all domains of daily life like personal hygiene, dressing, eating, communication, organization, and leisure, profoundly contribute to disease outcome. In their review about performance based measures of functional living skills, [@bib7] come to the conclusion that most identified instruments provide adequate reliability, but empirical data regarding their predictive validity for real life is limited. Nevertheless, the use of these instruments in medical outcome studies is recommended, since these functions are of major importance for the treatment outcome as perceived by the patients themselves, which should be the most important criterion for a successful treatment.

Other topics in this double-issue that are not addressed in this Editorial, include functional brain imaging, neuroendocrinology, genetics and gene expression, proteome and metabolome analysis. This impressively demonstrates the complexity of psychiatric research. We are very happy to announce that the publisher of the Journal of Psychiatric Research, Elsevier Ltd., has decided to increase the number of the yearly issues from eight to twelve, starting with this double-issue. Some of the upcoming issues will be published "off-catalog" in advance to the actual cover-date until the backlog of manuscripts in press and the administrative workflow allow publishing on schedule. The decision to increase the number of issues underlines that the rationale of this Journal to present a common platform for basic and clinical studies helps moving us forward to an integrated understanding of psychiatric disorders.
